Ardelyx

ARDX

Market cap $1.49B

6.15 USD

+0.32

5.49%

At close Updated Jan 2, 4:00 PM EST

Pre-market

After hours

6.28

+0.13

2.11%

1 day

5.49%

5 days

3.71%

1 month

11.01%

3 months

17.14%

6 months

46.78%

Year to date

20.12%

1 year

20.12%

5 years

-4.95%

10 years

-64.29%

About: Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Employees: 395

Healthcare Biotechnology